Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-22-012243
Filing Date
2022-08-04
Accepted
2022-08-04 16:31:47
Documents
72
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q tmb-20220630x10q.htm   iXBRL 10-Q 1346981
2 EX-31.1 tmb-20220630xex31d1.htm EX-31.1 9781
3 EX-31.2 tmb-20220630xex31d2.htm EX-31.2 9790
4 EX-32.1 tmb-20220630xex32d1.htm EX-32.1 6267
5 EX-32.2 tmb-20220630xex32d2.htm EX-32.2 6269
  Complete submission text file 0001558370-22-012243.txt   5911432

Data Files

Seq Description Document Type Size
6 EX-101.SCH tmb-20220630.xsd EX-101.SCH 46120
7 EX-101.CAL tmb-20220630_cal.xml EX-101.CAL 35860
8 EX-101.DEF tmb-20220630_def.xml EX-101.DEF 159321
9 EX-101.LAB tmb-20220630_lab.xml EX-101.LAB 311466
10 EX-101.PRE tmb-20220630_pre.xml EX-101.PRE 300071
66 EXTRACTED XBRL INSTANCE DOCUMENT tmb-20220630x10q_htm.xml XML 1063959
Mailing Address 84 OCTOBER HILL ROAD SUITE 11 HOLLISTON MA 01746
Business Address 84 OCTOBER HILL ROAD SUITE 11 HOLLISTON MA 01746 (774) 233-7300
Biostage, Inc. (Filer) CIK: 0001563665 (see all company filings)

EIN.: 455210462 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35853 | Film No.: 221137170
SIC: 3841 Surgical & Medical Instruments & Apparatus